Omnicell Inc (OMCL) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.025x

Based on the latest financial reports, Omnicell Inc (OMCL) has a cash flow conversion efficiency ratio of 0.025x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($30.35 Million) by net assets ($1.23 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Omnicell Inc market capitalisation for the company's overall valuation and market capitalisation.

Omnicell Inc - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how Omnicell Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Omnicell Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Omnicell Inc ranked by their cash flow conversion efficiency. Explore Omnicell Inc (OMCL) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Yantai Dongcheng Pharmaceutical Co Ltd
SHE:002675
0.044x
Hunan Oil Pump
SHG:603319
0.018x
HBM Healthcare Investments
SW:HBMN
0.000x
Mayr-Melnhof Karton AG
VI:MMK
0.120x
Global Ship Lease Inc
NYSE:GSL
0.065x
Dalian Huarui Heavy Industry Group Co Ltd
SHE:002204
-0.016x
KPIT Technologies Limited
NSE:KPITTECH
0.112x
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SHE:300357
0.032x

Annual Cash Flow Conversion Efficiency for Omnicell Inc (2000–2025)

The table below shows the annual cash flow conversion efficiency of Omnicell Inc from 2000 to 2025. View current stock price of Omnicell Inc for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $1.23 Billion $127.30 Million 0.103x -31.55%
2024-12-31 $1.24 Billion $187.72 Million 0.151x -0.87%
2023-12-31 $1.19 Billion $181.09 Million 0.152x +121.31%
2022-12-31 $1.13 Billion $77.78 Million 0.069x -65.95%
2021-12-31 $1.15 Billion $231.81 Million 0.202x +5.23%
2020-12-31 $967.50 Million $185.87 Million 0.192x +11.98%
2019-12-31 $845.25 Million $145.01 Million 0.172x +12.14%
2018-12-31 $679.62 Million $103.97 Million 0.153x +218.59%
2017-12-31 $517.20 Million $24.83 Million 0.048x -56.77%
2016-12-31 $431.61 Million $47.94 Million 0.111x +32.37%
2015-12-31 $402.39 Million $33.76 Million 0.084x -49.77%
2014-12-31 $390.10 Million $65.16 Million 0.167x +5.29%
2013-12-31 $348.33 Million $55.26 Million 0.159x +23.59%
2012-12-31 $307.58 Million $39.48 Million 0.128x +16.24%
2011-12-31 $282.91 Million $31.24 Million 0.110x +42.33%
2010-12-31 $265.49 Million $20.60 Million 0.078x -56.41%
2009-12-31 $242.30 Million $43.13 Million 0.178x +112.81%
2008-12-31 $233.56 Million $19.54 Million 0.084x -42.79%
2007-12-31 $254.64 Million $37.23 Million 0.146x -32.55%
2006-12-31 $90.00 Million $19.51 Million 0.217x +630.25%
2005-12-31 $55.24 Million $-2.26 Million -0.041x +48.98%
2004-12-31 $53.70 Million $-4.30 Million -0.080x -136.25%
2003-12-31 $34.76 Million $7.68 Million 0.221x +204.60%
2002-12-31 $16.31 Million $1.18 Million 0.073x +113.28%
2001-12-31 $19.60 Million $-10.71 Million -0.546x -171.56%
2000-12-31 $-25.02 Million $-19.11 Million 0.764x --

About Omnicell Inc

NASDAQ:OMCL USA Health Information Services
Market Cap
$1.53 Billion
Market Cap Rank
#7166 Global
#2189 in USA
Share Price
$33.66
Change (1 day)
+1.91%
52-Week Range
$29.46 - $51.39
All Time High
$183.62
About

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for th… Read more